Lifespan Cancer Institute at Rhode Island Hospital /ID# 261687 is a clinical research site located in Providence, Rhode Island, United States 02903-4923.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Lifespan Cancer Institute at Rhode Island Hospital /ID# 261687 has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer.
Sponsors: AbbVie.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Lifespan Cancer Institute at Rhode Island Hospital /ID# 261687 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lifespan Cancer Institute at Rhode Island Hospital /ID# 261687 has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Castration-Resistant Prostate Cancer.
Lifespan Cancer Institute at Rhode Island Hospital /ID# 261687 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.